Daratumumab Based Response Adapted Therapy for Older Adults With Newly Diagnosed Multiple Myeloma
Summary
Third Opinion Trial Synopsis:
This is a study where scientists are testing a new treatment for older people with a type of cancer called multiple myeloma. They want to see if using a special medicine called daratumumab can help treat the cancer.
This is a study where scientists are testing a new treatment for older people with a type of cancer called multiple myeloma. They want to see if using a special medicine called daratumumab can help treat the cancer.
*Third Opinion AI Generated Synopsis
Trial Summary
This is a Phase II study of daratumumab based therapies for older adults with multiple myeloma.
This is a Phase II study of daratumumab based therapies for older adults with multiple myeloma.
Locations & Contact
Fill out the form and "Notify Multiple Myeloma Research Foundation" to let the Multiple Myeloma Research Foundation know you are interested in this trial.
Contacts: